FromAstraZeneca ([email protected])
Subject (44)Imfinzi recommended in EU for bladder cancer
Preheader (131)Imfinzi recommended for approval in the EU by CHMP as first and only perioperative immunotherapy for muscle-invasive bladder cancer
Typography
Arial
Colors
Text Analysis
Body Words142
Subject Words7
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px770 px
X-Spam Score-1.9
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeOvernight

Imfinzi recommended in EU for bladder cancer

Imfinzi recommended for approval in the EU by CHMP as first and only perioperative immunotherapy for muscle-invasive bladder cancer
Imfinzi recommended in EU for bladder cancer